CARsgen Therapeutics (HKG:2171) said YIJIE Biotech and parties acting in concert with it acquired 100,000 additional shares in the firm between Nov. 6 and Nov. 10, a Thursday Hong Kong bourse filing said.
Shares of the biopharmaceutical company were up nearly 2% in Friday afternoon trading.
Substantial shareholder YIJIE Biotech and its concert parties now hold 218 million, or 37.92%, shares in the firm.